Developer docs
API playgroundTry for free, no card

Search company profiles

Регистр Лекарственных Средств России®

Full company profile

uuid00581ti

Namestring
Регистр Лекарственных Средств России®
Legal namestring
Регистр лекарственных средств России РЛС
Websiteurl
rlsnet.ru
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Регистр Лекарственных Средств России® (RLS®) operates rlsnet.ru, a Russian-language pharmaceutical reference encyclopedia founded in 2000 by Evgeny Gennadievich Vyshkovsky and headquartered in Moscow. The platform catalogs prescription and over-the-counter drugs, active pharmaceutical ingredients, manufacturers, and trade names, with structured ATC and ICD-10 classification lookups, manufacturer catalogs, and pharmacy price comparison data across multiple Russian chains. It also publishes the proprietary Vyshkovsky Popularity Index ranking prescription drug demand, and maintains a clinical reference section covering diseases, symptoms, and pharmacological categories. The user base spans three segments: healthcare professionals (physicians, pharmacists) seeking authoritative monographs; pharmacy chains and pharmaceutical manufacturers using the platform as an advertising and content distribution channel; and consumers searching for drug information and prices.

Short descriptiontext

RLS® operates rlsnet.ru, a Russian pharmaceutical reference encyclopedia founded in 2000. The platform serves healthcare professionals, pharmacy chains, and consumers with drug information, ATC/ICD-10 classifications, and pharmacy pricing, monetized via advertising and pharmacy affiliate referrals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMoscow, Russia
HQ citystring
Moscow
HQ countrystring
Russia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical reference database, drug encyclopedia services, ATC drug classification, pharmacy pricing data, drug information platform
Industry2 codes
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)
NAICS code1 code
  • Advertising, Public Relations, and Related Services5418
SIC code1 code
  • Services-Health Services8000
Product category
Pharmaceutical Reference and Drug Information Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Advertising
TypeAdvertising
Description

The platform generates revenue through advertising placements from pharmaceutical companies, manufacturers, and related healthcare companies. Multiple advertising blocks are visible throughout the site from various pharmaceutical entities.

rlsnet.ru
2Affiliate/Referral Revenue
TypeAffiliate Referral
Description

Integration with pharmacy chains (Apteka.ru, ASNA, Uteka, PlanetZdorovo, Gorzdrav, ZdesApteka) generates referral fees when users purchase drugs through affiliate links.

rlsnet.ru
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Consumer drug pricing displayed from pharmacy partners
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Individual drug prices displayed ranging from approximately 185 RUB (Nitrosprint spray) to 3,473 RUB (Diaflex Khondro capsules). Prices vary by pharmacy chain and dosage form.

rlsnet.ru
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Регистр Лекарственных Средств России® (RLS®) operates the rlsnet.ru online pharmaceutical reference encyclopedia, providing healthcare professionals, pharmacists, and consumers in Russia with comprehensive drug information including medical use instructions, descriptions of active pharmaceutical substances, dietary supplements, medical devices, ATC and ICD-10 classifications, drug analogue search, manufacturer directories, and real-time pharmacy pricing across Russian regions. The platform also publishes pharmaceutical news, hosts press releases from manufacturers, maintains a regulatory documents library, and tracks drug popularity through the proprietary Vyshkovsky Index.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Coverage includes all major Russian regions and cities for pricing information
Product overview1 text field

Регистр Лекарственных Средств России® РЛС® is a comprehensive pharmaceutical reference platform serving as the primary encyclopedia of drugs and pharmacy products in Russia. The platform operates as a unified information system centered on the Энциклопедия лекарственных препаратов РЛС® (RLS® Encyclopedia of Medications), which provides drug instructions, descriptions of diseases and pharmacological groups, ATC and ICD-10 classifications, and real-time pharmacy pricing. Supporting modules include: Указатель лекарств и субстанций (Drug and Substance Index), Указатель действующих веществ (Active Substance Index), АТХ классификация (ATC Classification), Указатель фармакологических групп (Pharmacological Group Index), Указатель фармакологических действий (Pharmacological Actions Index), Цены на ЖНВЛП (Vital Medicines Price Monitoring), Поиск аналогов (Drug Analogue Finder), Поиск регистрационных удостоверений (Registration Certificate Search), Производители (Manufacturer Directory), МКБ-10 and Указатель болезней (Disease Index), Медицинские калькуляторы (Medical Calculators), БАДы and ТАА indexes, Новости (News), Колонка главного редактора (Chief Editor Column), Библиотека (Library with normative acts, articles, patient education, books, patents), Электронные справочники для врачей (Electronic Physician Handbooks), and Индекс Вышковского (Vyshkovsky Popularity Index). The site is registered with Roskomnadzor (Эл № ФС77-85156, 2023) and is targeted exclusively at healthcare and pharmaceutical professionals.

Product and service1 record
1RLS® Encyclopedia of Medications (Энциклопедия лекарственных препаратов РЛС®)
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
1Pharmarf
Strategic tierModerateTypeGTM or Marketing Partner
Description

Professional medical publications platform partnership for pharmaceutical content distribution to healthcare professionals.

rlsnet.ru
2Vrachirf (Врачи РФ)
Strategic tierModerateTypeGTM or Marketing Partner
Description

Russian doctor professional network partnership for publishing pharmaceutical content and reaching medical professionals.

rlsnet.ru
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major Russian online pharmacy chain providing drug pricing integration and affiliate purchasing referrals.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Russian pharmacy chain providing pricing data integration with RLS platform.

5Planet Zdorovo (Планета здоровья)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmacy chain with pricing integration for prescription and OTC medications.

rlsnet.ru
6Gorzdrav (Горздрав)
Strategic tierModerateTypeChannel Partner/ Reseller/ Distributor
Description

Russian pharmacy chain providing pricing data for drugs listed on RLS platform.

rlsnet.ru
Strategic tierModerateTypeChannel Partner/ Reseller/ Distributor
Description

Online pharmacy platform with affiliate integration for drug pricing and availability.

8ZdesApteka (Здесь аптека)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional pharmacy chain providing pricing data for RLS drug listings.

rlsnet.ru
Strategic tierModerateTypeGTM or Marketing Partner
Description

German pharmaceutical company - products featured on RLS platform with detailed listings including Bronchipret, Canephron N, Sinupret, Cyclodynon, etc.

10Polisorb AO
Strategic tierModerateTypeGTM or Marketing Partner
Description

Russian pharmaceutical manufacturer - Polisorb MP adsorbent product listed in RLS encyclopedia.

rlsnet.ru
11Farmamed OOO
Strategic tierMinorTypeGTM or Marketing Partner
Description

Russian pharmaceutical company with cardiovascular products (Isakardin, Nitrosprint) listed on RLS.

rlsnet.ru
12S.C. Rompharm Company S.R.L.
Strategic tierMinorTypeGTM or Marketing Partner
Description

Romanian pharmaceutical company - Diaflex Khondro joint preparation listed in RLS.

rlsnet.ru
13Soteks FarmFirma (Сотекс ФармФирма)
Strategic tierModerateTypeGTM or Marketing Partner
Description

Russian pharmaceutical company featured as partner on RLS platform.

rlsnet.ru
Strategic tierModerateTypeGTM or Marketing Partner
Description

Russian pharmaceutical manufacturer listed as partner with products including Diaflex Khondro.

Strategic tierModerateTypeGTM or Marketing Partner
Description

International pharmaceutical company - products featured on RLS platform.

Strategic tierModerateTypeGTM or Marketing Partner
Description

Major international pharmaceutical company operating in Russia with products listed on RLS.

Strategic tierModerateTypeGTM or Marketing Partner
Description

German consumer health company with OTC products listed on RLS platform.

Strategic tierModerateTypeGTM or Marketing Partner
Description

Russian pharmaceutical company with products featured in RLS encyclopedia.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Comprehensive drug and drug-target knowledge base used by clinicians, researchers, and pharma companies — comparable to RLS as a structured drug reference, with similar classification system indexing and pharma customer base.

TypeDirect peer
Description

Clinical drug reference app used by US physicians for drug monographs, interactions, and formulary data — comparable to RLS as a healthcare-professional-focused drug information product, though delivered primarily via mobile.

TypeDirect peer
Description

Asia-Pacific drug reference and prescribing information platform covering multiple regional markets — same encyclopedia-plus-classification model as RLS, monetized via pharma industry subscriptions and advertising.

TypeBroad incumbent
Description

Physician-focused drug reference and clinical news platform owned by WebMD — comparable to RLS in serving healthcare professionals with drug monographs, but operates as part of a broader clinical information network.

5Drugs.com
TypeDirect peer
Description

Leading consumer and professional drug information platform offering monographs, interactions, pill identifier, and pricing — comparable to RLS as a search-first reference site monetized through pharma advertising.

6DailyMed
TypeBroad incumbent
Description

US National Library of Medicine's official drug-label repository providing authoritative FDA-approved drug information — analogous to Russia's state drug registry competing with RLS, and a benchmark for free official alternatives.

TypeDirect peer
Description

Drug monographs and consumer drug information site, part of the WebMD network — directly comparable to RLS as a drug-reference encyclopedia targeting both professionals and consumers with monographs and pill identifiers.

TypeDirect peer
Description

Original French drug reference directory serving physicians and pharmacists with monographs, interactions, and ATC classification — the closest functional analogue to RLS's encyclopedia model, demonstrating the same reference-plus-advertising business pattern in a different market.

TypeDirect peer
Description

Russian-language drug reference encyclopedia offering drug monographs, ATC classification, and pricing across the Russian pharmaceutical market — directly competing with RLS for the same healthcare-professional audience and same manufacturer advertising dollars.

10WebMD
TypeBroad incumbent
Description

Large US health information platform with drug monographs among a broader consumer health content portfolio — comparable to RLS in the drug reference and pharma advertising overlap, but a much larger general health destination.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Регистр Лекарственных Средств России®

Pharmaceutical Reference and Drug Information Servicesrlsnet.ru

RLS® operates rlsnet.ru, a Russian pharmaceutical reference encyclopedia founded in 2000. The platform serves healthcare professionals, pharmacy chains, and consumers with drug information, ATC/ICD-10 classifications, and pharmacy pricing, monetized via advertising and pharmacy affiliate referrals.

What Регистр Лекарственных Средств России® does

Регистр Лекарственных Средств России® (RLS®) operates rlsnet.ru, a Russian-language pharmaceutical reference encyclopedia founded in 2000 by Evgeny Gennadievich Vyshkovsky and headquartered in Moscow. The platform catalogs prescription and over-the-counter drugs, active pharmaceutical ingredients, manufacturers, and trade names, with structured ATC and ICD-10 classification lookups, manufacturer catalogs, and pharmacy price comparison data across multiple Russian chains. It also publishes the proprietary Vyshkovsky Popularity Index ranking prescription drug demand, and maintains a clinical reference section covering diseases, symptoms, and pharmacological categories. The user base spans three segments: healthcare professionals (physicians, pharmacists) seeking authoritative monographs; pharmacy chains and pharmaceutical manufacturers using the platform as an advertising and content distribution channel; and consumers searching for drug information and prices.

Регистр Лекарственных Средств России® firmographics

Firmographics
Name
Регистр Лекарственных Средств России®
Legal name
Регистр лекарственных средств России РЛС
Website
https://rlsnet.ru
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
RLS® operates rlsnet.ru, a Russian pharmaceutical reference encyclopedia founded in 2000. The platform serves healthcare professionals, pharmacy chains, and consumers with drug information, ATC/ICD-10 classifications, and pharmacy pricing, monetized via advertising and pharmacy affiliate referrals.
Ownership category
akta.pro rank

Регистр Лекарственных Средств России® industry classification

Industry
Product category
Pharmaceutical Reference and Drug Information Services
NAICS
Advertising, Public Relations, and Related Services (5418)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)

Keywords

  • Pharmaceutical reference database
  • Drug encyclopedia services
  • ATC drug classification
  • Pharmacy pricing data
  • Drug information platform

Where Регистр Лекарственных Средств России® is headquartered

Location

Headquarters

HQ city
Moscow
HQ country
Russia
HQ region
Europe

Offices1 record

Markets served

Регистр Лекарственных Средств России® business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Pharmaceutical Advertising: The platform generates revenue through advertising placements from pharmaceutical companies, manufacturers, and related healthcare companies. Multiple advertising blocks are visible throughout the site from various pharmaceutical entities.
  2. Affiliate/Referral Revenue: Integration with pharmacy chains (Apteka.ru, ASNA, Uteka, PlanetZdorovo, Gorzdrav, ZdesApteka) generates referral fees when users purchase drugs through affiliate links.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goConsumer drug pricing displayed from pharmacy partners

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Регистр Лекарственных Средств России® product offering

Product offering

Core offering

Регистр Лекарственных Средств России® (RLS®) operates the rlsnet.ru online pharmaceutical reference encyclopedia, providing healthcare professionals, pharmacists, and consumers in Russia with comprehensive drug information including medical use instructions, descriptions of active pharmaceutical substances, dietary supplements, medical devices, ATC and ICD-10 classifications, drug analogue search, manufacturer directories, and real-time pharmacy pricing across Russian regions. The platform also publishes pharmaceutical news, hosts press releases from manufacturers, maintains a regulatory documents library, and tracks drug popularity through the proprietary Vyshkovsky Index.

Product overview

Регистр Лекарственных Средств России® РЛС® is a comprehensive pharmaceutical reference platform serving as the primary encyclopedia of drugs and pharmacy products in Russia. The platform operates as a unified information system centered on the Энциклопедия лекарственных препаратов РЛС® (RLS® Encyclopedia of Medications), which provides drug instructions, descriptions of diseases and pharmacological groups, ATC and ICD-10 classifications, and real-time pharmacy pricing. Supporting modules include: Указатель лекарств и субстанций (Drug and Substance Index), Указатель действующих веществ (Active Substance Index), АТХ классификация (ATC Classification), Указатель фармакологических групп (Pharmacological Group Index), Указатель фармакологических действий (Pharmacological Actions Index), Цены на ЖНВЛП (Vital Medicines Price Monitoring), Поиск аналогов (Drug Analogue Finder), Поиск регистрационных удостоверений (Registration Certificate Search), Производители (Manufacturer Directory), МКБ-10 and Указатель болезней (Disease Index), Медицинские калькуляторы (Medical Calculators), БАДы and ТАА indexes, Новости (News), Колонка главного редактора (Chief Editor Column), Библиотека (Library with normative acts, articles, patient education, books, patents), Электронные справочники для врачей (Electronic Physician Handbooks), and Индекс Вышковского (Vyshkovsky Popularity Index). The site is registered with Roskomnadzor (Эл № ФС77-85156, 2023) and is targeted exclusively at healthcare and pharmaceutical professionals.

Differentiator

Problem solved

Functional benefit

Products and services

  • RLS® Encyclopedia of Medications (Энциклопедия лекарственных препаратов РЛС®)

Quantifiable outcome

  • Coverage includes all major Russian regions and cities for pricing information

Companies that use Регистр Лекарственных Средств России®

Customer profile

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Регистр Лекарственных Средств России® technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Регистр Лекарственных Средств России® partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered moderate, core and minor.

  • PharmarfmoderateGTM or Marketing PartnerProfessional medical publications platform partnership for pharmaceutical content distribution to healthcare professionals.
  • Vrachirf (Врачи РФ)moderateGTM or Marketing PartnerRussian doctor professional network partnership for publishing pharmaceutical content and reaching medical professionals.
  • Apteka.rucoreChannel Partner/ Reseller/ DistributorMajor Russian online pharmacy chain providing drug pricing integration and affiliate purchasing referrals.
  • ASNAcoreChannel Partner/ Reseller/ DistributorRussian pharmacy chain providing pricing data integration with RLS platform.
  • Planet Zdorovo (Планета здоровья)coreChannel Partner/ Reseller/ DistributorPharmacy chain with pricing integration for prescription and OTC medications.
  • Gorzdrav (Горздрав)moderateChannel Partner/ Reseller/ DistributorRussian pharmacy chain providing pricing data for drugs listed on RLS platform.
  • Uteka (Ютека)moderateChannel Partner/ Reseller/ DistributorOnline pharmacy platform with affiliate integration for drug pricing and availability.
  • ZdesApteka (Здесь аптека)minorChannel Partner/ Reseller/ DistributorRegional pharmacy chain providing pricing data for RLS drug listings.
  • Bionorica SEmoderateGTM or Marketing PartnerGerman pharmaceutical company - products featured on RLS platform with detailed listings including Bronchipret, Canephron N, Sinupret, Cyclodynon, etc.
  • Polisorb AOmoderateGTM or Marketing PartnerRussian pharmaceutical manufacturer - Polisorb MP adsorbent product listed in RLS encyclopedia.
  • Farmamed OOOminorGTM or Marketing PartnerRussian pharmaceutical company with cardiovascular products (Isakardin, Nitrosprint) listed on RLS.
  • S.C. Rompharm Company S.R.L.minorGTM or Marketing PartnerRomanian pharmaceutical company - Diaflex Khondro joint preparation listed in RLS.
  • Soteks FarmFirma (Сотекс ФармФирма)moderateGTM or Marketing PartnerRussian pharmaceutical company featured as partner on RLS platform.
  • Severnaya Zvezda NAO (Северная звезда)moderateGTM or Marketing PartnerRussian pharmaceutical manufacturer listed as partner with products including Diaflex Khondro.
  • Novartis PharmamoderateGTM or Marketing PartnerInternational pharmaceutical company - products featured on RLS platform.
  • Sanofi Rossiya AO (Санофи Россия)moderateGTM or Marketing PartnerMajor international pharmaceutical company operating in Russia with products listed on RLS.
  • Bayer AG, Division Consumer HealthmoderateGTM or Marketing PartnerGerman consumer health company with OTC products listed on RLS platform.
  • R-Pharm AO (Р-Фарм)moderateGTM or Marketing PartnerRussian pharmaceutical company with products featured in RLS encyclopedia.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Регистр Лекарственных Средств России® competitors and assessment

Company assessment

Direct peers

  • DrugBank: Comprehensive drug and drug-target knowledge base used by clinicians, researchers, and pharma companies — comparable to RLS as a structured drug reference, with similar classification system indexing and pharma customer base.
  • Epocrates: Clinical drug reference app used by US physicians for drug monographs, interactions, and formulary data — comparable to RLS as a healthcare-professional-focused drug information product, though delivered primarily via mobile.
  • MIMS: Asia-Pacific drug reference and prescribing information platform covering multiple regional markets — same encyclopedia-plus-classification model as RLS, monetized via pharma industry subscriptions and advertising.
  • Drugs.com: Leading consumer and professional drug information platform offering monographs, interactions, pill identifier, and pricing — comparable to RLS as a search-first reference site monetized through pharma advertising.
  • RxList: Drug monographs and consumer drug information site, part of the WebMD network — directly comparable to RLS as a drug-reference encyclopedia targeting both professionals and consumers with monographs and pill identifiers.
  • Vidal (France): Original French drug reference directory serving physicians and pharmacists with monographs, interactions, and ATC classification — the closest functional analogue to RLS's encyclopedia model, demonstrating the same reference-plus-advertising business pattern in a different market.
  • Vidal (vidal.ru): Russian-language drug reference encyclopedia offering drug monographs, ATC classification, and pricing across the Russian pharmaceutical market — directly competing with RLS for the same healthcare-professional audience and same manufacturer advertising dollars.

Broad incumbents

  • Medscape: Physician-focused drug reference and clinical news platform owned by WebMD — comparable to RLS in serving healthcare professionals with drug monographs, but operates as part of a broader clinical information network.
  • DailyMed: US National Library of Medicine's official drug-label repository providing authoritative FDA-approved drug information — analogous to Russia's state drug registry competing with RLS, and a benchmark for free official alternatives.
  • WebMD: Large US health information platform with drug monographs among a broader consumer health content portfolio — comparable to RLS in the drug reference and pharma advertising overlap, but a much larger general health destination.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Регистр Лекарственных Средств России® social profiles

Digital presence

Регистр Лекарственных Средств России® financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Регистр Лекарственных Средств России® leadership team

Management profile

Number of profiles

Регистр Лекарственных Средств России® funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Регистр Лекарственных Средств России® M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Регистр Лекарственных Средств России®

What does Регистр Лекарственных Средств России® do?

Регистр Лекарственных Средств России® (RLS®) operates the rlsnet.ru online pharmaceutical reference encyclopedia, providing healthcare professionals, pharmacists, and consumers in Russia with comprehensive drug information including medical use instructions, descriptions of active pharmaceutical substances, dietary supplements, medical devices, ATC and ICD-10 classifications, drug analogue search, manufacturer directories, and real-time pharmacy pricing across Russian regions. The platform also publishes pharmaceutical news, hosts press releases from manufacturers, maintains a regulatory documents library, and tracks drug popularity through the proprietary Vyshkovsky Index.

Is Регистр Лекарственных Средств России® a public or private company?

Регистр Лекарственных Средств России® is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Регистр Лекарственных Средств России® founded?

Регистр Лекарственных Средств России® was founded in 2000. It employs 11 to 50 people.

Where is Регистр Лекарственных Средств России® based?

Регистр Лекарственных Средств России® is headquartered in Moscow, Russia, in the Europe region.

How does Регистр Лекарственных Средств России® make money?

Two revenue lines are on record. Pharmaceutical Advertising is the primary driver. The others are affiliate/Referral Revenue.

Who are Регистр Лекарственных Средств России®'s main competitors?

Direct peers on record are DrugBank, Epocrates, MIMS, Drugs.com, RxList, Vidal (France) and Vidal (vidal.ru). Broad incumbents are Medscape, DailyMed and WebMD.

Does Регистр Лекарственных Средств России® have an API?

No public API is recorded for Регистр Лекарственных Средств России®.

What industry is Регистр Лекарственных Средств России® in?

Регистр Лекарственных Средств России®'s product category is Pharmaceutical Reference and Drug Information Services. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of CRAOAHAK, Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops). Its NAICS code is 5418 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales